Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

The single-scar technique in hair transplantation minimizes scarring and preserves hairs for future use, with proper training overcoming its perceived drawbacks.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Frog skin cells need the protein desmoplakin for proper development and cell layer formation.

Balding and low testosterone increase risk of urinary stones.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.